FREE T4 (THYTOXINE) MICROPLATE EIA TEST MODELS # 1225-300— 510(k) K020548

Name: FDA 510(k) clearance K020548
Creator: U.S. Food and Drug Administration
Published: 2002-04-05

Substantially Equivalent

Monobind

FDA 510(k) clearance K020548 for FREE T4 (THYTOXINE) MICROPLATE EIA TEST MODELS # 1225-300, Substantially Equivalent on 2002-04-05. Applicant: Monobind. Device class: 2.

Clearance details

Applicant: Monobind
Product code: Code CEC
Device class: Class 2
Regulation: 21 CFR 862.1695
Advisory panel: Clinical Chemistry
Date received: 2002-02-19
Decision date: 2002-04-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Costa Mesa, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CEC

view all

K240273 — Access Free T42024-03-06
K220456 — Elecsys FT4 IV2023-04-07
K182423 — MAGLUMI 2000 FT42018-10-04
K181233 — Elecsys FT4 III2018-09-18
K173122 — Abbott Architect Free T42017-10-27

More clearances from Monobind

view all

K030860 — ACCUBIND NEONATAL T4 MICROPLATE EIA, MODEL 2625-3002003-08-22
K980088 — T-UPTAKE MICROPLATE EIA1998-02-04
K972720 — FOLLICLE STIMULATING HORMONE (FSH) MICROPLATE ELISA (425-300)1997-09-02
K971834 — ANTI-THYROID PEROXIDASE (TPO) MICROPLATE ELISA1997-07-03
K971835 — ANTI-THYROGLOBULIN (TG) MICROPLATE ELISA1997-07-03

Adverse events under product code CEC

product code CEC

Malfunction: 899
Total: 899

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.